期刊
DIABETES OBESITY & METABOLISM
卷 25, 期 -, 页码 3-20出版社
WILEY
DOI: 10.1111/dom.15059
关键词
CSII; cost-effectiveness; glycaemic control; insulin pump therapy
The global prevalence and increasing incidence rates of type 2 diabetes (T2D) have significant impacts on healthcare costs and quality of life. However, the use of continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, is underutilized in T2D management despite technological advances. This review examines the literature on CSII use in T2D patients, discusses potential benefits for specific patient groups, identifies challenges associated with CSII use, and proposes future research directions to expand its applicability to a broader T2D population.
The global prevalence and increasing incidence rates of type 2 diabetes (T2D) have rippling effects on healthcare costs and diminishing quality of life. Despite advances in technology, continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, is rarely being recommended by healthcare professionals and is underutilized in T2D management. This review analyses the available literature on CSII use in T2D patients. In addition, it discusses which groups of patients may benefit from CSII, identifies potential challenges associated with CSII use, and suggests future directions for research to expand the applicability of this technology to the broader T2D population.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据